Neuropharmacological Therapy of Carcinoid Syndrome

Publisher： Karger

E-ISSN： 1423-0194|81|3|137-138

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.81, Iss.3, 2005-07, pp. : 137-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Interventional Treatment of the Carcinoid Syndrome

By  

Neuroendocrinology, Vol. 80, Iss. 1, 2004-10 ,pp. : 67-73

Karger

Access to resources Recommend Favorite

Complications of Midgut Carcinoid Tumors and Carcinoid Syndrome

By  

Neuroendocrinology, Vol. 80, Iss. 1, 2004-10 ,pp. : 28-32

Karger

Access to resources Recommend Favorite

Ectopic ACTH Cushing’s Syndrome: V3 Vasopressin Receptor But Not CRH Receptor Gene Expression in a Pulmonary Carcinoid Tumor

By  

Hormone Research in Paediatrics, Vol. 50, Iss. 4, 1998-12 ,pp. : 226-231

Karger

Access to resources Recommend Favorite

Octreotide Exerts Only Acute, but No Sustained, Effects on MRI Enhancement of Liver Metastases in Carcinoid Syndrome

By  

Neuroendocrinology, Vol. 82, Iss. 1, 2006-01 ,pp. : 41-48

Karger

Access to resources Recommend Favorite

Rapid and Sustained Relief from the Symptoms of Carcinoid Syndrome: Results from an Open 6-Month Study of the 28-Day Prolonged-Release Formulation of Lanreotide

By  

Neuroendocrinology, Vol. 80, Iss. 4, 2005-01 ,pp. : 244-251

Karger

Access to resources Recommend Favorite